Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 May 2:7:18.
doi: 10.1186/1471-2288-7-18.

Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes

Carl Heneghan  1 , Rafael Perera, Alison Ward A, David Fitzmaurice, Emma Meats, Paul Glasziou
Affiliations
Comparative Study

Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes

Carl Heneghan et al. BMC Med Res Methodol. .

Abstract

Background: Analyzing drop out rates and when they occur may give important information about the patient characteristics and trial characteristics that affect the overall uptake of an intervention.

Methods: We searched Medline and the Cochrane library from the beginning of the databases to May 2006 for published systematic reviews that compared the effects of self-monitoring (self-testing) or self-management (self-testing and self-dosage) of oral anticoagulation or self-monitored blood glucose in type 2 diabetics who were not using insulin. We assessed all study withdrawals pre-randomization and post randomization and sought information on the reasons for discontinuation of all participants.To measure the differential between groups in attrition we used the relative attrition (RA), which is equivalent to relative risk but uses attrition as the outcome (i.e. attrition in intervention group/attrition in control group). We determined the percentage drop outs for control and intervention groups and used DerSimonian and Laird random effects models to estimate a pooled relative attrition. L'abbe type plots created in R (version 2.0.2) were used to represent the difference in the relative attrition among the trials with 95% confidence areas and weights derived from the random effects model.

Results: With self-monitoring of blood glucose in type 2 diabetes, attrition ranged from 2.3% to 50.0% in the intervention groups and 0% to 40.4% in the control groups. There was no significant difference between the intervention and control, with an overall RA of 1.18 [95% CI, 0.70-2.01]. With self-monitoring of oral anticoagulation attrition ranged from 0% to 43.2% in the intervention groups and 0% to 21.4% in the control group. The RA was significantly greater in the intervention group, combined RA, 6.05 [95% CI, 2.53-14.49].

Conclusion: This paper demonstrates the use of relative attrition as a new tool in systematic review methodology which has the potential to identify patient, intervention and trial characteristics which influences attrition in trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diabetes attrition L'abbe plot.
Figure 2
Figure 2
Diabetes attrition Forest plot.
Figure 3
Figure 3
Oral anticoagulation attrition L'abbe plot.
Figure 4
Figure 4
Oral anticoagulation attrition Forest plot.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet. 2002;359:781–785. doi: 10.1016/S0140-6736(02)07882-0. - DOI - PubMed
    1. Tierney JF, Stewart LA. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol. 2005;34:79–87. doi: 10.1093/ije/dyh300. - DOI - PubMed
    1. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367:404–411. doi: 10.1016/S0140-6736(06)68139-7. - DOI - PubMed
    1. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, Passa P, Thivolet C, Vialettes B, Charbonnel B. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29:587–594. doi: 10.1016/S1262-3636(07)70073-3. - DOI - PubMed
    1. Rutten G, van Eijk J, de Nobel E, Beek M, van , V Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract. 1990;7:273–278. doi: 10.1093/fampra/7.4.273. - DOI - PubMed

Publication types

MeSH terms